$56.28 +0.06 (0.11%) Bristol-Myers Squibb Co - New York Stock Exchange, Inc.

Jan. 17, 2017 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 56.28
Trade Time: Jan 17 04:00 PM Eastern Daylight Time
Change: +0.06 (0.11%)
Prev Close: 56.22
Open: 55.89
Bid: 56.19
Ask: 56.36

Competitors

Ticker Name Volume % Change
AZN AstraZeneca Group plc 7.32M -0.38%
CELG Celgene Corporation 5.35M -2.15%
CGC.TO Canopy Growth Corporation 1.26M +1.01%
INVA Innoviva Inc. 982.62K -4.14%
IRWD Ironwood Pharmaceuticals, Inc. 884.24K -4.02%

BMY Stock Analysis

Partner Headlines

  1. FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    Investors Business Daily | Jan. 17, 2017 | 14:21PM EST
  2. Analysts See Merck Rally Continuing After Lung Cancer Drug News

    TalkMarkets | Jan. 12, 2017 | 14:31PM EST
  3. Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva

    Investors Business Daily | Jan. 12, 2017 | 14:00PM EST
  4. Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst

    Investors Business Daily | Jan. 12, 2017 | 11:14AM EST
  5. Stocks Wipe Away Losses, Close Higher; Drug Stocks Feel Trump Thump

    Investors Business Daily | Jan. 11, 2017 | 16:21PM EST
  6. Merck Lung-Cancer Drug May Get OK For Large Patient Population

    Investors Business Daily | Jan. 11, 2017 | 12:28PM EST